Quince Therapeutics, Inc. (NASDAQ:QNCX) Short Interest Update

Quince Therapeutics, Inc. (NASDAQ:QNCX – Get Free Report) saw a large decline in short interest in January. As of January 31st, there was short interest totalling 1,900,000 shares, a decline of 7.3% from the January 15th total of 2,050,000 shares. Based on an average daily trading volume, of 91,100 shares, the short-interest ratio is presently […]

Leave a Reply

Your email address will not be published.

Previous post Regulus Therapeutics Inc. (NASDAQ:RGLS) Short Interest Update
Next post Streamline Health Solutions, Inc. (NASDAQ:STRM) Short Interest Down 7.1% in January